Business Card for Barry Goldberg:


Director, Patient and Specialty Services
 Morristown, NJ area
Email Avail: 3 Day Free Trial


PO BOX 8803
Emeryville, CA 94662-0803
Tel: (412) 777-4889

Last updated on 2018-03-29

About Barry Goldberg:

Barry Goldberg works as an Director, Patient and Specialty Services for Bayer AG at Morristown, NJ. The company's webpage is http://www.bayer.com. For email, phone number and executive profiles for Director, Patient and Specialty Services and other executives of Bayer AG at Morristown, NJ, check Bayer AG at Joesdata.com. Not the Barry Goldberg you are looking for? Do a quick search in our website and find other people named Barry Goldberg.
Barry Goldberg's Work History:
No information available..

Barry Goldberg's Education:
Rutgers
The State University of New Jersey-Newark
Rutgers University-New Brunswick.

Barry Goldberg's Co-workers:
As of December 6, 2019, Barry Goldberg has 149 co-workers under the company name Bayer AG at Joesdata.com.

About Bayer AG:


Warning: mysqli_fetch_assoc() expects parameter 1 to be mysqli_result, boolean given in /home2/joesdata/public_html/login/executivedetails.php on line 392
Bayer AG is located at PO BOX 8803, Emeryville, CA 94662-0803. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-04 19:18:31
LEO Pharma Closes Acquisition of Bayers Prescription Dermatology Business in the United States
2018-09-04 17:12:14
LEO Pharma Closes Acquisition of Bayers Prescription Dermatology Business in the United States
2018-07-31 17:30:32
LEO Pharma to Expand Its Lead in Medical Dermatology with Acquisition of Bayers Prescription Dermatology Unit
2018-07-31 17:06:18
LEO Pharma to Expand Its Lead in Medical Dermatology with Acquisition of Bayers Prescription Dermatology Unit
2017-02-10 19:18:39
Bayer announces Phase III COMPASS study1 shows efficacy of Xarelto (rivaroxaban) for the prevention of major adverse cardiac events in patients with coronary or peripheral artery disease and meets primary endpoint early
2017-02-10 17:30:29
Bayer announces Phase III COMPASS study1 shows efficacy of Xarelto (rivaroxaban) for the prevention of major adverse cardiac events in patients with coronary or peripheral artery disease and meets primary endpoint early
2016-09-14 21:00:40
Bayer and Monsanto to Create a Global Leader in Agriculture

People in the same industry:

Ken Bowen
VP - Production
Amerex Corporation

Chris Fong
Director Data Management
Amgen Inc.

Carl Jaeschke
Director-MDM, Global Data Warehouse,/Reporting/Ana
Ecolab Inc.

Dave Defrancisco
Associate Director Data Center Support
Pfizer Incorporated

Deborah Herbst
Director of Data Analytics
Pfizer Incorporated

Diane Gardner
Director, Database Ops
Celgene Corporation